222 - Optimizing PK/PD of New Antibiotics Against MDR Organisms

10/5/2019

10:30 AM - 11:45 AM

Room: Walter E. Washington Convention Center, 146 ABC

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-402-L01-P

Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

assess the impact of infections due to MDR organisms on patient outcomes
distinguish the merits of new antibiotics
formulate effective treatment strategies for infections due to MDR organisms

Presentations:

10:30 AM - 10:55 AM
1934 - Beta-lactam / beta-lactamase inhibitor combinations
Marc H. Scheetz, PharmD, MSc – Midwestern University/Northwestern Memorial Hospital
10:55 AM - 11:20 AM
1935 - Plazomicin: A novel once-daily aminoglycoside
Kamilia Abdelraouf, PhD – Center for Anti-Infective Research and Development/Hartford Hospital
11:20 AM - 11:45 AM
1936 - New Tetracycline Derivatives (Omadacycline and Eravacycline)
Alexander Lepak, MD – University of Wisconsin

Moderator(s)

Vincent Tam, PharmD

Professor
University of Houston
Houston, Texas

Disclosure: Nothing to disclose
Elizabeth Hirsch, PharmD

Assistant Professor
University of Minnesota
Minneapolis, MN

Disclosure: Merck: Grant/Research Support, Research Grant
Nabriva Therapeutics: Advisory Board
Paratek Pharmaceuticals: Advisory Board

Speaker(s)

Kamilia Abdelraouf, PhD

Associate Director
Center for Anti-Infective Research and Development/Hartford Hospital
Hartford, CT

Disclosure: Nothing to disclose
Alexander Lepak, MD

Assistant Professor
University of Wisconsin
Madison, WI

Disclosure: Paratek Pharmaceuticals: Research Grant
Tetraphase Pharmaceuticals: Research Grant
Marc Scheetz, PharmD, MSc

Professor of Pharmacy and Pharmacology; Director, Pharmacometrics Center of Excellence
Midwestern University/Northwestern Memorial Hospital
Chicago, IL

Disclosure: Allecra: Grant/Research Support
Merck, Sharpe, and Dohme: Grant/Research Support
Nevakar: Grant/Research Support